APA (7th ed.) Citation

A, F., SR, R., S, O., SV, G., LH, M., ND, A., . . . HP, M. (2019). Anti-tumor Activity of the Type I PRMT Inhibitor, GSK3368715, Synergizes with PRMT5 Inhibition through MTAP Loss. Cancer cell, 36(1), 100. https://doi.org/10.1016/j.ccell.2019.05.014

Chicago Style (17th ed.) Citation

A, Fedoriw, et al. "Anti-tumor Activity of the Type I PRMT Inhibitor, GSK3368715, Synergizes with PRMT5 Inhibition Through MTAP Loss." Cancer Cell 36, no. 1 (2019): 100. https://doi.org/10.1016/j.ccell.2019.05.014.

MLA (9th ed.) Citation

A, Fedoriw, et al. "Anti-tumor Activity of the Type I PRMT Inhibitor, GSK3368715, Synergizes with PRMT5 Inhibition Through MTAP Loss." Cancer Cell, vol. 36, no. 1, 2019, p. 100, https://doi.org/10.1016/j.ccell.2019.05.014.